XWELL, Inc. (NASDAQ:XWEL) Sees Large Increase in Short Interest

XWELL, Inc. (NASDAQ:XWEL) was the target of a large growth in short interest in January. As of January 30th, there was short interest totaling 226,787 shares, a growth of 219.9% from the January 15th total of 70,903 shares. Currently, 4.6% of the shares of the stock are sold short. Based on an average daily volume of 1,899,514 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily volume of 1,899,514 shares, the days-to-cover ratio is currently 0.1 days. Currently, 4.6% of the shares of the stock are sold short.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of XWELL in a research report on Wednesday, January 21st. One analyst has rated the stock with a Sell rating, According to MarketBeat, XWELL has a consensus rating of “Sell”.

XWELL Stock Down 8.2%

Shares of NASDAQ XWEL opened at $0.36 on Wednesday. XWELL has a 12-month low of $0.26 and a 12-month high of $1.42. The firm’s 50-day simple moving average is $0.52 and its 200 day simple moving average is $0.83. The company has a market cap of $2.07 million, a price-to-earnings ratio of -0.11 and a beta of 1.51.

XWELL (NASDAQ:XWEL) last posted its quarterly earnings data on Friday, November 14th. The company reported ($0.26) earnings per share for the quarter. XWELL had a negative net margin of 51.85% and a negative return on equity of 352.37%. The company had revenue of $7.35 million during the quarter.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.